JP2017502946A5 - - Google Patents

Download PDF

Info

Publication number
JP2017502946A5
JP2017502946A5 JP2016539089A JP2016539089A JP2017502946A5 JP 2017502946 A5 JP2017502946 A5 JP 2017502946A5 JP 2016539089 A JP2016539089 A JP 2016539089A JP 2016539089 A JP2016539089 A JP 2016539089A JP 2017502946 A5 JP2017502946 A5 JP 2017502946A5
Authority
JP
Japan
Prior art keywords
radioactive
formula
radiotracer
radiopharmaceutical composition
content
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016539089A
Other languages
English (en)
Japanese (ja)
Other versions
JP6824738B2 (ja
JP2017502946A (ja
Filing date
Publication date
Priority claimed from GBGB1322456.3A external-priority patent/GB201322456D0/en
Application filed filed Critical
Publication of JP2017502946A publication Critical patent/JP2017502946A/ja
Publication of JP2017502946A5 publication Critical patent/JP2017502946A5/ja
Application granted granted Critical
Publication of JP6824738B2 publication Critical patent/JP6824738B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016539089A 2013-12-18 2014-12-18 放射性トレーサー組成物及び方法 Active JP6824738B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1322456.3 2013-12-18
GBGB1322456.3A GB201322456D0 (en) 2013-12-18 2013-12-18 Radiotracer compositions and methods
PCT/EP2014/078609 WO2015091882A1 (en) 2013-12-18 2014-12-18 Radiotracer compositions and methods

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019124883A Division JP2019206533A (ja) 2013-12-18 2019-07-04 放射性トレーサー組成物及び方法

Publications (3)

Publication Number Publication Date
JP2017502946A JP2017502946A (ja) 2017-01-26
JP2017502946A5 true JP2017502946A5 (enExample) 2017-12-28
JP6824738B2 JP6824738B2 (ja) 2021-02-03

Family

ID=50071052

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016539089A Active JP6824738B2 (ja) 2013-12-18 2014-12-18 放射性トレーサー組成物及び方法
JP2019124883A Withdrawn JP2019206533A (ja) 2013-12-18 2019-07-04 放射性トレーサー組成物及び方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019124883A Withdrawn JP2019206533A (ja) 2013-12-18 2019-07-04 放射性トレーサー組成物及び方法

Country Status (6)

Country Link
US (3) US10300156B2 (enExample)
EP (1) EP3082879A1 (enExample)
JP (2) JP6824738B2 (enExample)
CN (1) CN105848687B (enExample)
GB (1) GB201322456D0 (enExample)
WO (1) WO2015091882A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
GB201322456D0 (en) * 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods
CN108218651B (zh) * 2018-02-27 2023-11-03 首都医科大学宣武医院 用于制备放射性药物的一次性辅助装置及方法
GB201804835D0 (en) * 2018-03-26 2018-05-09 Ge Healthcare As Formulation and method of preparation
GB201805253D0 (en) * 2018-03-29 2018-05-16 Ge Healthcare Ltd Ip Solid phase extraction
GB201915206D0 (en) 2019-10-21 2019-12-04 Ge Healthcare Ltd Use of cyclodextrins as a radiostabilizer
GB201919016D0 (en) * 2019-12-20 2020-02-05 Ge Healthcare Ltd Apparatus and method for solid phase extraction
MX2022008571A (es) * 2020-01-10 2022-11-30 Real Isolates Llc Metodos para la obtencion de compuestos a partir de un material vegetal o de hongos, composiciones respectivas y usos de los mismos.

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5961955A (en) 1997-06-03 1999-10-05 Coulter Pharmaceutical, Inc. Radioprotectant for peptides labeled with radioisotope
GB0105224D0 (en) 2001-03-02 2001-04-18 Nycomed Amersham Plc Improved peptide-chelate conjugates
GB0116815D0 (en) 2001-07-10 2001-08-29 Nycomed Amersham Plc Improved chelator conjugates
TWI240632B (en) 2001-07-30 2005-10-01 Epix Medical Inc Purified peptides for peptide-based multimeric targeted contrast agents
EP1516185A4 (en) 2001-12-27 2007-06-20 Van Andel Res Inst Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor
ATE473019T1 (de) * 2002-11-05 2010-07-15 Ion Beam Applic Sa Stabilisierung von wässerigen zusammensetzungen von 18f-markiertem 2-fluoro-2-deoxy-d-glukose mit ethanol
US7018614B2 (en) 2002-11-05 2006-03-28 Eastern Isotopes, Inc. Stabilization of radiopharmaceuticals labeled with 18-F
NO20030115D0 (no) 2003-01-09 2003-01-09 Amersham Health As Kontrastmiddel
EP2284180B1 (en) 2003-03-03 2015-09-09 Dyax Corp. Uses of peptides that specifically bind HGF receptor (cMET)
GB0305704D0 (en) 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods
GB0420344D0 (en) 2004-09-14 2004-10-13 Amersham Plc Diagnostic compounds
EP1952826A4 (en) 2005-10-24 2011-05-18 Fujifilm Ri Pharma Co Ltd DIAGNOSTIC AGENT AND THERAPEUTIC AGENT FOR DISEASES RELATED TO THE HEPATOCYTE GROWTH FACTOR RECEPTOR
JP2009542689A (ja) 2006-07-07 2009-12-03 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ 選択的カスパーゼ阻害剤
GB0615211D0 (en) 2006-07-31 2006-09-06 Ge Healthcare Uk Ltd Asymmetric flouro-substituted polymethine dyes
AU2007294124A1 (en) 2006-09-08 2008-03-13 Bayer Schering Pharma Aktiengesellschaft Compounds and methods for 18F labeled agents
US7902332B2 (en) 2006-11-30 2011-03-08 General Electric Company Fluorine-labeled compounds
WO2008072976A2 (en) 2006-12-13 2008-06-19 Ge Healthcare As Synthesis of a radiofluorinated peptide using microwave activation technology
KR20090119966A (ko) 2007-03-01 2009-11-23 바이엘 쉐링 파마 악티엔게젤샤프트 진단 영상화제로서의 18f 플루오로-벤조일 표지된 생물학적 활성 화합물, 벤조트리아졸-1-일옥시-벤조일, 2,5-디옥소-피롤리딘-1-일옥시)벤조일 및 트리메틸암모니오-벤조일 전구체
JP2010526859A (ja) 2007-05-16 2010-08-05 ジーイー・ヘルスケア・アクスイェ・セルスカプ ペプチドイメージング剤
GB0718957D0 (en) 2007-09-28 2007-11-07 Ge Healthcare Ltd Optical imaging agents
GB0718967D0 (en) 2007-09-28 2007-11-07 Ge Healthcare Ltd Peptide imaging agents
GB0716897D0 (en) 2007-08-30 2007-10-10 Univ Muenchen Tech Cancer imaging and treatment
US20090274623A1 (en) * 2008-01-30 2009-11-05 General Electric Company In vivo imaging agents for met receptor tyrosine kinase
GB0803477D0 (en) 2008-02-26 2008-04-02 Ge Healthcare As Therapy selection method
JP5399422B2 (ja) * 2008-02-28 2014-01-29 ジーイー・ヘルスケア・リミテッド 市販の安価な化学薬品からのpeg−6成分の合成
US8435454B2 (en) * 2009-07-09 2013-05-07 Siemens Medical Solutions Usa, Inc. Modular system for radiosynthesis with multi-run capabilities and reduced risk of radiation exposure
AU2010273319B2 (en) 2009-07-15 2015-01-22 Nestec S.A. Drug selection for gastric cancer therapy using antibody-based arrays
EP2287197A1 (en) 2009-08-21 2011-02-23 Pierre Fabre Medicament Anti-cMET antibody and its use for the detection and the diagnosis of cancer
GB0918321D0 (en) 2009-10-20 2009-12-02 Ge Healthcare As Cyclic peptide synthesis
GB201013808D0 (en) 2010-08-18 2010-09-29 Ge Healthcare Ltd Peptide radiotracer compositions
GB201020314D0 (en) 2010-12-01 2011-01-12 Ge Healthcare Ltd Apoptosis pet imaging agents
CA2819347A1 (en) 2010-12-01 2012-06-07 Ge Healthcare Limited Radioconjugation method
US9180213B2 (en) * 2010-12-09 2015-11-10 Ge Healthcare Limited Radiotracer compositions
BR112013015580A2 (pt) * 2010-12-21 2016-10-04 Ge Healthcare Ltd método de radioestabilização
NZ612327A (en) 2010-12-22 2015-03-27 Ge Healthcare Ltd Her2 binding peptides labelled with a 18f - containing organosilicon compound
GB201103696D0 (en) 2011-03-04 2011-04-20 Ge Healthcare Ltd Technetium labelled peptides
GB201121914D0 (en) 2011-12-20 2012-02-01 Ge Healthcare Ltd Method for patient selection
GB201202420D0 (en) 2012-02-13 2012-03-28 Ge Healthcare Ltd Radiotracer compositions
GB201209082D0 (en) * 2012-05-24 2012-07-04 Ge Healthcare Ltd Purification method
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
GB201322456D0 (en) * 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods
GB201322451D0 (en) 2013-12-18 2014-02-05 Ge Healthcare Ltd Purification method and compositions

Similar Documents

Publication Publication Date Title
CN102712603B (zh) 放射性碘标记方法
JP2022136074A (ja) 新規製剤及び合成方法
IL224463A (en) Peptide radiotracer compositions
CN103889930B (zh) 用于制备68Ga络合物的工艺
CN105848687B (zh) 放射性示踪剂组合物和方法
Haveman et al. State of the art procedures towards reactive [18F] fluoride in PET tracer synthesis
JP2018536031A (ja) ジアリールヨードニウム塩を使用してヨード−又はアスタトアレーンを合成するための方法
Craig et al. Preparation of labeled aromatic amino acids via late-stage 18 F-fluorination of chiral nickel and copper complexes
KR102109225B1 (ko) 18f-플루시클로빈의 제조
EP4305009A2 (en) Aliphatic 18f-radiolabeling of a tetrazine precursor
ES2654528T3 (es) Procedimiento de preparación de un derivado de purina marcado, dicho derivado y sus usos
ES2892034T3 (es) Proceso para la purificación de Ga-68 a partir del eluato derivado de generadores de 68Ge/ 68Ga
US20100228060A1 (en) Perfluoro-aryliodonium salts in nucleophilic aromatic 18f-fluorination
US20140127130A1 (en) Radiofluorinated compounds and their preparation
JP2017501152A5 (enExample)
JP2015516457A (ja) 放射性医薬品の製造用キット及び製造方法
Mahmood et al. 10. TECHNETIUM RADIOPHARMACEUTICALS
WO2018233798A1 (en) Novel psma-binding agents and uses thereof
KR102084472B1 (ko) 다양한 압타머에 적용 가능한 방사성동위원소 표지된 핵산 구조체 개발 및 표지방법
WO2013113801A2 (en) Chelating agents
Chiotellis et al. Synthesis, characterization and biological evaluation of novel neutral fac-M (CO) 3 (SNO) complexes (M= Re, 99mTc) bearing the o-methoxyphenylpiperazine moiety
Meltzer et al. A second-generation 99mTechnetium single photon emission computed tomography agent that provides in vivo images of the dopamine transporter in primate brain
US20160022845A1 (en) Synthon composition
US20120093726A1 (en) Radiolabeled Fluorine Derivatives of Methionine
EP4696686A1 (en) Fapi theranostic compounds assembled with tetrazine ligation